Targets of perturbagens

Perturbagen ID Perturbagen Reference Target Number Response ID
CID56621 Cytisine; (1r,5s)-1,2,3,4,5,6-hexahydro-1,5-methano-8h-pyrido[1,2a][1,5]diazocin-8-one; Baptitoxine; Sophorine; Ulexin DrugBank; CLUE; STITCH 21  RID39454 RID39455 RID39456 RID39457 RID39458 RID39459 RID39623 RID39624 RID39625 RID39626 RID39627 RID39628 RID39791 RID39792 RID39793 RID39794 RID39795 RID39796
CID56622 Cosentyx; Secukinumab DrugBank 1  NA
CID56623 Miltefosine; Hdpc; Hexadecyl 2-(trimethylazaniumyl)ethyl phosphate; Hexadecylphosphocholine; Hexadecylphosphorylcholine; Impavido; Miltefosin; Miltefosina; Miltéfosine; Monohexadecylphosphocholine; Monohexadecylphosphorylcholine CLUE; STITCH; DrugBank 3  RID32758 RID32759 RID32760 RID32761 RID32762 RID32763 RID32948 RID32949 RID32950 RID32951 RID32952 RID32953 RID33135 RID33136 RID33137 RID33138 RID33139 RID33140
CID56624 Entyvio; Vedolizumab DrugBank 2  NA
CID56625 [(7r)-4-(5-chlor-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl]methanon; [(7r)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl]methanone; [(7r)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-méthyl-1,4-diazépan-1-yl][5-méthyl-2-(2h-1,2,3-triazol-2-yl)phényl]méthanone; [(7r)-4-(5-chlorobenzoxazol-2-yl)-7-methylhexahydro-1h-1,4-diazepin-1-yl][5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl]methanone; Belsomra; Suvorexant DrugBank; STITCH 2  NA
CID56626 Nivolumab; Opdivo DrugBank 1  NA
CID56627 Siltuximab; Sylvant DrugBank 1  NA
CID56628 Keytruda; Lambrolizumab; Pembrolizumab DrugBank 1  NA
CID56629 Empagliflozin; (1s)-1,5-anhydro-1-(4-chloro-3-{4-[(3s)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-d-glucitol; 1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene; Jardiance DrugBank; CLUE; STITCH 2  RID35167 RID35168 RID35169 RID35170 RID35171 RID35172 RID35304 RID35305 RID35306 RID35307 RID35308 RID35309 RID35439 RID35440 RID35441 RID35442 RID35443 RID35444
CID56630 (2r,3r)-2-(2,4-difluorophenyl)-3-(4-methylene-1-piperidinyl)-1-(1h-1,2,4-triazol-1-yl)-2-butanol; Efinaconazole; Jublia DrugBank; CLUE 2  NA